C84.7 Catégorie · précision supplémentaire requise Anaplastic large cell lymphoma, ALK-negative
ICD-10-CM C84.7 identifies “Anaplastic large cell lymphoma, ALK-negative” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Excludes 11
primary cutaneous CD30-positive T-cell proliferations (C86.6-)
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84 · Mature T/NK-cell lymphomas
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
Codes plus précis
C84.70Anaplastic large cell lymphoma, ALK-negative, unspecified siteCode facturable et spécifiqueC84.71Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neckCode facturable et spécifiqueC84.72Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodesCode facturable et spécifiqueC84.73Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodesCode facturable et spécifiqueC84.74Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limbCode facturable et spécifiqueC84.75Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limbCode facturable et spécifiqueC84.76Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodesCode facturable et spécifiqueC84.77Anaplastic large cell lymphoma, ALK-negative, spleenCode facturable et spécifiqueC84.78Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sitesCode facturable et spécifiqueC84.79Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sitesCode facturable et spécifiqueC84.7AAnaplastic large cell lymphoma, ALK-negative, breastCode facturable et spécifiqueC84.7BAnaplastic large cell lymphoma, ALK-negative, in remissionCode facturable et spécifiqueRéférences de l’index officiel
Références de l’index officiel (1)
Lymphoma(of) (malignant) (1)
- Lymphoma(of) (malignant) › anaplastic large cell › ALK-negativeIndex des maladies
Références depuis d’autres codes (1)
Excludes 1 · anaplastic large cell lymphoma, ALK negative (C84.7-)
Historique
Historique du code
Aucune modification depuis la première observation
ModifiéInchangé
FY2016
En vigueur dès le
- Première observation
Anaplastic large cell lymphoma, ALK-negative
Catégorie — choisir un code plus précis
CDC/NCHS · FY2016Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Aucun changement tabulaire |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.